Blog Posts

Seguro de Gastos Funerarios| Fsinsurance.us

Posted by First Service Consulting on March 28, 2024 at 7:44am 0 Comments

¿Disponer del mejor seguro de gastos funerarios? Fsinsurance.us ofrece el mejor seguro de gastos funerarios a un precio asequible. Nuestro seguro de vida brinda la mayor protección, servicio y soluciones, y todos se benefician. Visite nuestro sitio para más información.



seguro de gastos funerarios…



Continue

SERVER THAILAND

Posted by SpaDeals123 on March 28, 2024 at 7:38am 0 Comments

https://kejari.pa-sukabumi.go.id/vinci/server-thailand/

Situs Judi Slot Server Thailand Terpercaya no 1 Pasti Super Gacor. Situs Judi Slot Server Thailand Terpercaya no 1 Pasti Super Gacor

수원출장마사지

Posted by QKSEO on March 28, 2024 at 7:38am 0 Comments

수원대표출장마사지 시크릿출장마사지를 찾아주셔서 감사합니다 수원 동탄 오산 전지역 30분 도착을 목표로 영업하고있는 프라이빗 수원출장안마 대표업체 입니다 선잆금 없는 출장마사지로써 언제나 노력하는 수원출장안마 수원출장 시크릿이 되도록 노력하겠습니다 수원 한국인 홈케어, 수원 일본인 홈케어, 수원횟수 무제한, 예약비 없는 수원출장, 출장 부르는법 디시, 출장 단속, 수원 홈케어, 수원 러시아. 수원 일본인 홈케어, 횟수 무제한 출장뜻 https://massage-here.com/

Holistic Healing: Integrating Body, Mind, and Spirit for Pain Relief

Posted by Rick Taylor on March 28, 2024 at 7:35am 0 Comments

Pain is a universal human experience, serving as a signal that something is wrong within the body. Whether it's acute or chronic, physical or emotional, pain can significantly impact an individual's quality of life. Effective pain management is crucial not only for alleviating suffering but also for restoring function and promoting overall well-being. In this article, we will explore the complexities of pain, various treatment modalities, and strategies for finding… Continue

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of ADCs.
 Elaborate profiles of the clinical stage companies (shortlisted based on phase of development of the lead drug) and their respective product portfolios.
 An analysis of the most commonly targeted therapeutic indications and details of ADC candidates being developed against them, highlighting key epidemiological facts about the diseases and currently available treatment options, other than ADCs.
 A list of key opinion leaders (KOLs) within this domain.
 An insightful competitiveness analysis of biological targets.
 An analysis of the partnerships that have been established in the recent past.
 An analysis of the investments made.
 A study of the various grants that have been awarded to research institutes engaged in projects related to ADCs, between 2011 and 2019 (till April).
 An elaborate discussion on the various strategies that can be adopted by the drug developers across key commercialization stages, namely prior to product launch, during / post launch.
 An analysis of the key promotional strategies that have been adopted by the developers of marketed products.
 An assessment of the various therapeutics that are being evaluated in combination with ADCs.
 A review of the evolution of ADC conjugation technologies.
 An overview of the studies conducted to better analyze non-clinical data and support first-in-human (FIH) dose selection in ADCs.
 An elaborate discussion on various factors that form the basis for the pricing of ADC products.
 A case study on manufacturing of ADCs, highlighting the key challenges, and a list of contract service providers that are involved in this domain.
 A case study on companies offering companion diagnostics.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of payload
 MMAE
 DM4
 Camptothecin
 AM1
 MMAF
 Type of Antibody Drug Conjugates Market (5th Edition), 2019-2030.er
 VC
 Sulfo-SPDB
 SMCC
 VA
 Hydrazone Antibody Drug Conjugates Market (5th Edition), 2019-2030.er
 Others
 Target Indications
 Breast Cancer
 Lymphoma
 Leukemia
 Urothelial cancer
 Lung cancer
 Ovaria cancer
 Others
 Target Antigen
 CD30
 HER2
 CD22
 CD33
 Others
 Small Molecule
 Technology Providers
 Seattle Genetics
 ImmunoGen
 StemCentRx
 Immunomedics
 Others
 Key Geographies
 North America
 Europe
 Asia Pacific

Transcripts of interviews held with the following senior level representatives of stakeholder companies:
 Alan Burnett (Professor, School of Medicine, Cardiff University)
 Aldo Braca (President and Chief Executive Officer) and Giorgio Salciarini (Technical Business Development Senior Manager, BSP Pharmaceuticals)
 Anthony DeBoer (Director, Business Development, Synaffix)
 Christian Bailly (Director of CDMO, Pierre Fabre)
 Christian Rohlff, (Chief Executive Officer and Founder, Oxford BioTherapeutics)
 Denis Angioletti (Chief Commercial Officer, Cerbios-Pharma)
 John Burt (Chief Executive Officer, Abzena)
 Jennifer L. Mitcham (Director, SMARTag ADCs and Bioconjugates) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)
 Laurent Ducry (Head of Bioconjugates Commercial Development, Lonza)
 Mark Wright (Site Head, Piramal Healthcare)
 Sasha Koniev (Chief Executive Officer & Co-Founder, Syndivia)
 Tatsuya Okuzumi (Associate General Manager, Ajinomoto Bio-Pharma Services)
 Toshimitsu Uenaka (Executive Director) and Takashi Owa (Chief Innovation Officer, Eisai)
 Wouter Verhoeven (Chief Business Officer, NBE-Therapeutics)

Key companies covered in the report
 Bristol Myers Squibb
 AbbVie
 Astellas Pharma
 AstraZeneca
 Daiichi Sankyo
 Pfizer
 Roche / Genentech
 Synthon
 Bayer HealthCare
 Biotest Pharmaceuticals

For more information please click on the following-
https://www.rootsanalysis.com/reports/view_document/antibody-drug-c...

Other Offerings
1. ADC Contract Manufacturing Market (3rd Edition), 2018-2030
2. Gene Therapy Market (3rd Edition), 2019 - 2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

Views: 0

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service